Technology
Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren’t Buying It.
Xavier Martinez·Wall Street Journal·November 4, 2026
No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle.
Read the full story at Wall Street Journal →